Abstract Valve-in-valve (ViV) (ViV-TAVI) with failed bioprostheses arose as an alternative to redo surgical (SAVR). To evaluate all-cause mortality in ViV-TAVI versus redo-SAVR, we performed a study-level meta-analysis of reconstructed time-to-event data from..
Read More